Overview of the National Agency for the Safety of Medicines and Health Products (ANSM) and Medical Device Regulation in France
An overview of the role of ANSM in France, focusing on market surveillance, clinical trial authorization, and the safety of medical devices under EU regulations.
Overview
Summary of this regulator or jurisdiction and how it relates to market access.
National Agency for the Safety of Medicines and Health Products (ANSM) - France
The ANSM (Agence nationale de sécurité du médicament et des produits de santé) is the competent authority in France responsible for assessing the benefits and risks of health products throughout their life cycle. For medical devices, its primary role is to ensure patient safety through rigorous market surveillance and regulatory oversight.
1. Regulatory Mission and Authority
Unlike medicinal products, medical devices in France do not require a marketing authorization (MA) directly from the ANSM before entering the market. Instead, they must obtain a CE marking via a Notified Body. However, the ANSM intervenes in several critical areas:
- Clinical Investigations: The ANSM evaluates and authorizes requests to conduct clinical trials for medical devices in France to ensure the protection of participants and the scientific validity of the data.
- Market Surveillance: The agency monitors products already on the market through proactive controls and inspections of manufacturing sites.
- Materiovigilance: This is the monitoring of incidents or risks of incidents resulting from the use of medical devices. The ANSM collects and analyzes reports from healthcare professionals, manufacturers, and patients.
2. Key Responsibilities
- Incident Management: Taking corrective actions, such as withdrawing a product from the market or issuing safety alerts (Field Safety Notices).
- Advertising Control: For certain high-risk medical devices, the ANSM must provide prior authorization for advertising intended for the public or professionals.
- Implementation of EU Regulations: Ensuring the transition and strict compliance with the EU Medical Device Regulation (MDR) 2017/745 and the In Vitro Diagnostic Regulation (IVDR) 2017/746.
3. Collaboration
The ANSM works closely with the European Medicines Agency (EMA) and other national competent authorities within the EU to harmonize safety standards and respond to health crises effectively.
Articles & guides
Insight articles mapped to this region on ElendiLabs.